Hospital, Novel Anti-Infectives Commercial Development Director


At Pfizer Hospital, we are committed to delivering breakthroughs that change both standard of care for patients as well as standard of practice for our hospital stakeholders. Our portfolio is unique in its breadth and depth with over 300+ products across 14 therapeutic areas. We are the #1 player globally in Anti-infectives and the #1 Global Sterile Injectables company. In 2021 alone, the Hospital business touched the lives of over 200 M patients globally.

The novel AI pipeline is at an exciting stage and is expanding rapidly. It has anti-bacterial assets both in pre-POC and one asset in PIII development: ATM-AVI (a breakthrough for the targeted treatment of patients with Gram-negative bacterial infections), CTB-AVP (a breakthrough oral agents to treat ESBL-producing and carbapenem-resistant Enterobacteriaceae), SPR206 (a breakthrough licensed asset that is being developed to address serious Gram-negative bacterial infections). Our lead anti-fungal asset, Fosmanogepix acquired from Amplyx is in PII development for the treatment of invasive fungal infections. In addition, we are expanding into the anti-viral space building on our internally developed Paxlovid Franchise and respiratory anti-viral assets acquired through BD.

The Commercial Development Director will be responsible for one of the three anti-infectives segments; anti-bacterial, anti-fungal or anti-viral. Within its segment the role is responsible for maximization of global value of the anti-infective assets in the portfolio and potentially other new novel molecules. The Director will be directly responsible for defining the commercial strategy for the pipeline asset/assets, and the initial focus will be to lead and deliver the commercial preparation for the DP3 decisions. The key responsibilities will include product, market development and go to market strategy and post DP3 launch preparedness with key collaboration from R&D, PH&I, Regulatory, PGS and global, regional & country marketing stakeholders. The partnership with global marketing and commercial regions is core to enable an effective handover of the asset to global marketing prior to launch. The role reports to the Senior Director Hospital, Novel Anti-Infectives, Search & Development Lead.

As a leader in this dynamic business, this individual will demonstrate and develop

Key Leader Behaviors including Leadership – influencing and empowering team members and colleagues to strive for excellence and make the right decisions in these innovative programs

Commercial Excellence – setting bold strategies to evolve the business model maximize the long-term value of these programs

Internal Ambassador - representing these key programs and optimizing internal connections and resources tobringthe best value of others (country, region,global and HQ) to create a collaborative expandednetwork​


  • Manages the development pipeline of either anti-bacterial (AB), anti-fungal (AF) or anti-viral (AV) assets in development and other novel/differentiated assets transferred from ESD or pursued through BD.

  • Commercial lead for the global medicine team (GMT), providing strategic commercial input and leading a commercial sub-team to the GMT.

  • Interacts with and influences a broad range of functions involved with the development and commercialization of the pipeline; including R&D, medical, clinical, regulatory, business assessments, global/regional commercial, PH&I, BAI, finance, and legal functions to ensure that DP3 & launch plans are coordinated and supported

  • Develop and execute the commercial development plan & forecasts to inform the key DP3 decision to initiate pivotal trials.

  • Represents the “Voice of the Customer”; monitors overall AI landscape of expertise and trends to provides commercial insights, assessments, and strategic guidance as part of the GMT

  • Serves as the commercial lead for all regions and provide guidance for shaping global and regional priorities to ensure successful launch planning. Works closely with regions to ensure alignment with forecasts/P&Ls during development phase

  • Works with global marketing team and regions to ensure timely and seamless transition pre-launch

  • Supports/leads key commercial development projects for the specific are of expertise; AB, AF or AV


  • 10 years of broad pharmaceutical experience (marketing, strategy, business development, new product launch, portfolio strategy, commercial development)

  • Experience in anti-infectives brand marketing and/or product development

  • Proven leadership and demonstrated ability to drive cross-functional collaboration in a matrixed organization

  • Excellent written and oral communication skills including presenting opportunities/plans

  • Hands-on experience leading forecasting, P&Ls, business case generation etc.

  • Strong project management skills

  • Strong financial and analytical skills including P&L understanding and valuation metrics

  • Experience interfacing/collaborating with Research, Development, Regulatory etc.

  • Highly collaborative; ability to work well with teams

  • Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop, and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.


  • 20% travel


  • Last Date to Apply for Job: June 7, 2022.

  • Work Location: US remote

  • Eligible for employee referral bonus.

Pfizer requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Pfizer will consider requests for Reasonable Accommodations.

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.

Marketing and Market Research

#LI-Remote #LI-PFE